Medicines for Europe

medicinesforeurope.com

Medicines for Europe began over 20 years ago as the European Generics Medicines Association (EGA) with the goal of representing the emerging generic industry, and later growing to include biosimilar medicines to its portfolio. As the pharmaceutical industry and the healthcare environment within which it operates have evolved, so has our Association. When the association was first launched back in 1993, generic alternatives to branded medicines made up a fraction of the market. As more of these medicines came off-patent, and the benefits and value of generics to both patients and healthcare providers became clearer, so the provision of generic medicines has increased dramatically.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

HEALTH CANADA APPROVES IPSEN’S SOHONOS™ (PALOVAROTENE CAPSULES) AS THE FIRST APPROVED TREATMENT FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Ipsen | January 24, 2022

news image

Ipsen announced the Health Canada approval of Sohonos, an oral selective retinoic-acid receptor gamma agonist indicated to reduce the formation of heterotopic ossification in adults and children aged 8 years and above for females and 10 years and above for males with fibrodysplasia ossificans progressiva.1 Sohonos is approved for the treatment of patients with FOP for both chronic use, and for flare-ups, in these patient populations. This decision marks the first approval for Sohonos worldwide.<...

Read More

Pharmacy Market

ATHENEX, INC. REACHES AGREEMENT WITH LENDERS TO PURSUE EXPEDITED SALES PROCESS

Globenewswire | May 16, 2023

news image

Athenex, Inc. a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that, following an ongoing strategic review, it has reached agreement with its lenders to move forward with an expedited sales process of the Company’s assets across its primary businesses: Athenex Pharmaceutical Division (“APD”), Orascovery, and Cell Therapy. To be...

Read More

Business Insights

CORVAL™ LAUNCHES NEW BIOPHARMA COMMERCIALIZATION PLANNING PLATFORM

Corval | September 22, 2021

news image

Corval LLC announced the launch of its cloud-based commercialization planning platform designed for early- to mid-stage biopharma companies. Created by industry veterans with deep experience in biopharma commercialization, the platform provides a technology-based approach that expedites the commercialization planning process and helps teams align on strategic decisions, timing, and future resourcing needs. I have spent my entire career in this space and been exposed ...

Read More

US WILL BE WORLD'S PREMIER PHARMACY DRUG STORE AND MEDICAL MANUFACTURER: TRUMP

cnbctv18 | May 21, 2020

news image

The COVID-19 pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation, US President Donald Trump said on Thursday declaring the goal of making his country the world's premier pharmacy, drug store, and medical manufacturer. "The global pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation.... Today, I'm declaring a simple but vital national goal. The United States will be the world's ...

Read More
news image

Business Insights

HEALTH CANADA APPROVES IPSEN’S SOHONOS™ (PALOVAROTENE CAPSULES) AS THE FIRST APPROVED TREATMENT FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Ipsen | January 24, 2022

Ipsen announced the Health Canada approval of Sohonos, an oral selective retinoic-acid receptor gamma agonist indicated to reduce the formation of heterotopic ossification in adults and children aged 8 years and above for females and 10 years and above for males with fibrodysplasia ossificans progressiva.1 Sohonos is approved for the treatment of patients with FOP for both chronic use, and for flare-ups, in these patient populations. This decision marks the first approval for Sohonos worldwide.<...

Read More
news image

Pharmacy Market

ATHENEX, INC. REACHES AGREEMENT WITH LENDERS TO PURSUE EXPEDITED SALES PROCESS

Globenewswire | May 16, 2023

Athenex, Inc. a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that, following an ongoing strategic review, it has reached agreement with its lenders to move forward with an expedited sales process of the Company’s assets across its primary businesses: Athenex Pharmaceutical Division (“APD”), Orascovery, and Cell Therapy. To be...

Read More
news image

Business Insights

CORVAL™ LAUNCHES NEW BIOPHARMA COMMERCIALIZATION PLANNING PLATFORM

Corval | September 22, 2021

Corval LLC announced the launch of its cloud-based commercialization planning platform designed for early- to mid-stage biopharma companies. Created by industry veterans with deep experience in biopharma commercialization, the platform provides a technology-based approach that expedites the commercialization planning process and helps teams align on strategic decisions, timing, and future resourcing needs. I have spent my entire career in this space and been exposed ...

Read More
news image

US WILL BE WORLD'S PREMIER PHARMACY DRUG STORE AND MEDICAL MANUFACTURER: TRUMP

cnbctv18 | May 21, 2020

The COVID-19 pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation, US President Donald Trump said on Thursday declaring the goal of making his country the world's premier pharmacy, drug store, and medical manufacturer. "The global pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation.... Today, I'm declaring a simple but vital national goal. The United States will be the world's ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us